Imagion Biosystems (IBX.AX) Stock Price

Imagion Biosystems Price

ASX·CLOSED
0.01
​
Market closed

Over the last 11 years Imagion Biosystems grew revenue by 16.4% annually, reaching 32,370.00 AUD. For Imagion Biosystems, the net margin of -13,313.1% is down versus -2,587.2% a few years ago.

Imagion Biosystems stock price

Access this data via the Eulerpool API

Imagion Biosystems business model & stock analysis

Imagion Biosystems Ltd. engages in the research and development of non-radioactive and safe diagnostic imaging technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-06-22. The Company’s principal activity consists of nanotechnology, biotechnology, cancer diagnostics, and medical imaging using superparamagnetic relaxometry. The firm operates through Research and Development segment. Its MagSense technology is a functional imaging agent for detecting cancers and other critical diseases. MagSense technology uses bio-safe magnetic nanoparticles that are cancer-specific. MagSense nanoparticles are specially formulated as an injectable solution for each type of cancer. MagSense applications include breast cancer, prostate cancer, and ovarian cancer. The firm is conducting a Phase I clinical study of its MagSense HER2 imaging agent. Its PrecisionMRX nanoparticles have been developed for magnetic relaxometry and other demanding biomedical applications. Its PrecisionMRX products include Dextran-Coated, mPEG Coated, Oleic Acid Coated and Carboxylic Acid Functionalized.

Frequently asked questions about Imagion Biosystems

Converted at the current exchange rate, the Imagion Biosystems share trades at 0.00 EUR (0.01 AUD).

The Imagion Biosystems share (IBX.AX) is listed on 1 stock exchanges, including: ASX (IBX.AX).

The revenue cannot currently be calculated for Imagion Biosystems.

The profit cannot currently be calculated for Imagion Biosystems.

The P/E ratio cannot be calculated for Imagion Biosystems at the moment.

The P/S cannot be calculated for Imagion Biosystems currently.

The Eulerpool Quality Score for Imagion Biosystems is 3/10.

The ISIN of Imagion Biosystems is AU000000IBX6. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Imagion Biosystems is IBX.AX. The ticker symbol is used to trade Imagion Biosystems shares on the stock exchange.

Fair ValueTerminal
0.00 AUD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Australia
Currency
AUD
Initial public offering
Jun 22, 2017
ISIN
AU000000IBX6
Cusip
Q4878T190
Market capitalization
1.66 M AUDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
0.36
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-1,070.74 %
Last updated Oct 12, 2026, 8:32 AM

Imagion Biosystems Peer Group

Imagion Biosystems Ticker

ASX · IBX.AX

Imagion Biosystems FIGI

IBX:AU · BBG00GVKGY12IBX:AT · BBG00H0JK007IBX:AH · BBG00H0JK043IBXXF:US · BBG00X27K9Z9IBXXF:PQ · BBG00X27KBD8IBXXF:UV · BBG00X27KBF6